Home
Contact
Careers
Terms and Conditions
Privacy Policy
About Arcturus
RNA Medicines
Technologies
Pipeline
Business Development
Publications
Investor Relations

Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response

August 31, 2022

Home
Contact
Careers
Terms and Conditions
Privacy Policy
© 2023 Arcturus Therapeutics, Inc.